Ron Price - May 12, 2021 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Head of Commercial Operations
Signature: /s/ Steven Reichling, attorney-in-fact
Stock symbol: AXDX
Transactions as of: May 12, 2021
Transactions value $: -$42,466
Form type: 4
Date filed: 5/14/2021, 04:22 PM
Next filing: Mar 30, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Options Exercise		+19.3K	+1031.75%		21.2K	May 12, 2021	Direct	F1
transaction	AXDX	Common Stock	Sale	-$42.5K	-6.28K	-29.62%	$6.76	14.9K	May 13, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-19.3K	-100%	$0.00^*	0	May 12, 2021	Common Stock	19.3K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 12, 2021, the reporting person was granted restricted stock units, which vested in full on May 12, 2021.
F2	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.